Skip to main content

03-06-2017 | Advanced breast cancer | Article

MONARCH 2: Abemaciclib in Combination With Fulvestrant in Women With HR+/HER2− Advanced Breast Cancer Who Had Progressed While Receiving Endocrine Therapy

Sledge Jr GW et al. J Clin Oncol 2017; 35(25): 2875-2884. doi:10.1200/JCO.2017.73.7585

Please log in to get access to this content

Related topics